Remission achievable with usual care for axial spondyloarthritis
For patients with axial spondyloarthritis (axSpA), remission is attainable with usual care, according to a study published in the Journal of Rheumatology.
18 hours ago
0
5
MeSH tree: C05.550.069
For patients with axial spondyloarthritis (axSpA), remission is attainable with usual care, according to a study published in the Journal of Rheumatology.
18 hours ago
0
5
Axial spondyloarthritis (axSpA) is an inflammatory condition that causes chronic back pain and, if left untreated, can lead to fusion of the spinal or sacroiliac joints. The condition frequently remains underdiagnosed, with ...
Sep 10, 2026
0
7
A study initiated by the European Spondyloarthritis Research Collaboration Network (EuroSpA) examined whether patients' countries of residence are associated with the severity of their psoriatic arthritis (PsA) or axial spondyloarthritis ...
Aug 11, 2026
0
2
For patients with axial spondyloarthritis (axSpA), bimekizumab, a dual interleukin (IL)-17A and IL-17F inhibitor, is well tolerated over three years, according to a study published in the June issue of the Journal of Rheumatology.
Jul 9, 2026
0
7
Researchers at Academia Sinica have developed the first population-specific polygenic risk score (PRS) models for people of Han Chinese ancestry, achieving unprecedented accuracy in predicting risks for common diseases such ...
Nov 21, 2025
0
24
Over 60% of us will suffer from lower back pain at some point in our lives. Without question, it's the leading cause of disability across the globe.
Sep 4, 2025
0
15
Almost a quarter of Australians with back and neck pain have changed their work status due to their conditions, according to the first annual report from the Australian Longitudinal Study on Back and Neck Pain.
Mar 11, 2025
0
17
Genetically predicted rheumatoid arthritis (RA) is causally associated with prostate cancer (PCa), according to a study published online Jan. 10 in Medicine.
Jan 29, 2025
0
21
The U.S. Food and Drug Administration has approved Bimzelx (bimekizumab-bkzx) for the treatment of adults with active psoriatic arthritis (PsA), adults with active nonradiographic axial spondyloarthritis (nr-axSpA) with objective ...
Sep 26, 2024
0
35
There is a need to improve cross-sectoral care for people with inflammatory arthritis. The Danish Centre for Expertise in Rheumatology (CeViG) at the Danish Hospital for Rheumatic Diseases in Sønderborg, Denmark, is a unique ...
Jun 14, 2024
0
57